Alignment Healthcare (ALHC) Q3 2026 Earnings Call Transcript
Alignment Healthcare (ALHC) reported Q3 2026 earnings, with revenue of $1.4B (up 37% YoY) and adjusted gross profit of $142M. The company lowered annual guidance due to higher costs, targeting adjusted gross profit of at least $575M and adjusted EBITDA of $100M. Membership grew 31% YoY to 301,200. ALHC is addressing cost pressures and investing in clinical programs for 2027 growth.
How this was made

The 30-second read
Why it matters
The key tradable update is the lowered annual guidance tied to Q3 cost pressures, alongside operational initiatives (payment integrity, clinical resource deployment, and Stars workflow improvements) aimed at stabilizing margins and improving quality metrics.
Market read
Traders should focus on the guidance cut and the stated cost drivers (appeals/disputes, skilled nursing/catastrophic cases) versus management’s claim of stabilization and remediation progress.
What to watch
Stars remediation actions are already operationalized for the 2026 performance cycle, which could improve future quality bonus economics and offset some margin pressure if execution holds.
Background
The article is a transcript of Alignment Healthcare’s Q3 2026 earnings call, covering claims system migration, medical cost drivers, Stars performance, and full-year outlook.
Ticker impact
Alignment Healthcare cut annual guidance after Q3 cost pressures from higher provider appeals/disputes and skilled nursing/catastrophic cases, while reporting Q3 membership and margin metrics.
Likely downward pressure as the market reprices the remainder-of-year cost outlook and the credibility of margin stabilization actions.
The call explicitly lowers annual adjusted gross profit and adjusted EBITDA guidance and attributes the Q3 deterioration to identifiable cost drivers, which are direct inputs to forward earnings expectations.
Market effects
Managed-care and Medicare Advantage-style cost and Stars execution risk is highlighted, reinforcing scrutiny on medical cost ratio drivers and payment integrity/appeals dynamics.
California HMO Stars shortfall points to state-level execution risk for plans with concentrated exposure.
Limited direct global linkage; primarily affects US healthcare managed-care sentiment and valuation multiples tied to margin durability.
Counterpoint
The company reports institutional acute cost trends stabilized into October and says the guidance is confident, suggesting the cost spike may be more contained than the guidance cut implies.
Key entities
- companyAlignment Healthcare
US-listed managed care provider reporting Q3 2026 results, Stars performance updates, and lowered annual guidance.
- executiveJames Head
Speaker who discussed Q3 results, membership growth, margin metrics, and guidance details.
- executiveJohn
Speaker who discussed claims migration, cost headwinds, and Stars payment year 2028 rating drivers.



